SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of NK.SET™.